MindMed begins Phase 3 trials of LSD-based treatment for anxiety
MindMed, a U.S.-based pharmaceutical company, has initiated Phase 3 clinical trials for its LSD-based drug, MM120 (lysergide d-tartrate), targeting generalized…
MindMed, a U.S.-based pharmaceutical company, has initiated Phase 3 clinical trials for its LSD-based drug, MM120 (lysergide d-tartrate), targeting generalized…
Jennie Allen, the author of “Get Out of Your Head,” has released a new book aimed at addressing the rising…
Anxiety disorders affect many employees in the workplace, impacting their ability to perform effectively. According to a 2023 study published…
Political anxiety is becoming a prevalent issue, with experts highlighting its growing impact on mental health. Amanda Friesen, a political…
In Tupelo, mental health professionals underscore that anxiety is a common reaction to stressors—situations that create pressure or tension. According…
Diabetes mellitus, a significant global health issue, is closely linked to increased rates of anxiety disorders among patients. Epidemiological studies…
A recent report from Glassdoor reveals a significant decline in employee confidence in April, coinciding with rising anxiety linked to…
As youth depression and anxiety rates rise, the International Netball Festival offers a platform for young people to connect and…
Wisconsin mental health officials report a concerning trend among teen boys, with rising levels of anxiety, depression, and suicidal thoughts.…
Workplace stress and anxiety in the U.S. have increased significantly, with nearly 24% of workers seeking help for anxiety related…